Skip to main content
. 2023 Oct 4;2023(10):CD004417. doi: 10.1002/14651858.CD004417.pub6

De la Poza Abad 2016.

Study characteristics
Methods Randomised controlled trial over 2.5 years
Participants 405 adults with uncomplicated respiratory infections presenting to 23 primary healthcare centres in Spain. 398 participants were randomised: 198 to delayed antibiotics (100 to prescription collection strategy and 98 to patient‐led prescription strategy), 101 to immediate antibiotics and 99 to no antibiotics.
Age: the average age of participants in the prescription collection delayed antibiotic strategy was 42 years (SD 17); the patient‐led prescription delayed antibiotic strategy 45 years (SD 17); the immediate antibiotic group 48 years (SD 17); and the no antibiotic group 45 years (SD 16)
Sex:delayed antibiotics (prescription collection) group: 29 males, 71 females; delayed antibiotics (patient‐led prescription) group: 33 males, 65 females; immediate antibiotic group: 39 males, 61 females; no antibiotic group: 35 males, 64 females
Exclusion criteria: not reported
Interventions Delayed antibiotics (patient‐led prescription strategy) versus delayed antibiotics (prescription collection strategy) versus immediate antibiotics versus no antibiotics
Outcomes Primary outcomes: duration of symptoms, severity of symptoms, antibiotic use, patient satisfaction
Secondary outcomes: participants' beliefs about the effectiveness of antibiotics
All outcomes were measured using a patient diary
Notes Grant funding came from a joint initiative of the Spanish federal government and the European Regional Development Fund. Study authors were approached for extra information and these data were obtained.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Participants were centrally randomised using an e‐online platform
Allocation concealment (selection bias) High risk Not described
Blinding (performance bias and detection bias)
All outcomes High risk No blinding undertaken
Incomplete outcome data (attrition bias)
All outcomes Low risk 405 participants were recruited and 398 included in the analysis; 3 lost to follow‐up in delayed group, 4 lost to follow‐up in the immediate/no prescription group. Intention‐to‐treat guided all analyses.
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk Funded by government body